emtricitabine
Drug Details
- Generic Name
- emtricitabine
- Brand Names
- emtricitabine
- Application Number
- ANDA091168
- Sponsor
- Macleods Pharmaceuticals Limited
- NDC Codes
- 3
- Dosage Forms
- POWDER, CAPSULE
- Routes
- ORAL
- Active Ingredients
- EMTRICITABINE
Indications and Usage
1 INDICATIONS AND USAGE Efavirenz, Emtricitabine and Tenofovir disoproxil fumarate tablet is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablet is a three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. ( 1 )